Financial reports

Ascelia Pharma is a biotech company focused on orphan oncology treatments. We develop and commercialize novel drugs that address unmet medical needs and have a clear development and market pathway.

Headquarter is in Malmö, Sweden, and the company’s shares are listed on Nasdaq Stockholm (ticker: ACE)

Download our fact sheet: Ascelia Pharma Factsheet Dec 2020

Ascelia Pharma company presentation March 2021

• 2021-04-09Issue and repurchase of series C shares for share saving program
• 2021-03-31NOTICE OF ANNUAL GENERAL MEETING IN ASCELIA PHARMA AB
• 2021-03-31Number of shares and votes in Ascelia Pharma AB
• 2021-03-30Ascelia Pharma publishes Annual Report for 2020
• 2021-03-17Notice of extraordinary general meeting in Ascelia Pharma

• April 28 @ 11:15 - 11:35

  Redeye Orphan Drugs Seminar – April 2021

• May 5 @ 14:00 - 16:00

  Annual General Meeting 2021

• May 12 @ 08:00

  Interim Report Q1 2021 (January-March 2021)

• May 25

  ABGSC Life Science Summit

• August 19 @ 08:00

  Half-year report 2021 (April-June 2021)